Navigation Links
Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes

RESEARCH TRIANGLE PARK, N.C., Sept. 18 /PRNewswire-FirstCall/ -- Siemens Medical Solutions ( and Xintek Inc. announce today that they have signed an agreement to establish a joint venture company in Research Triangle Park, N.C. The mission of the new company, named XinRay Systems, is to develop a new multi-pixel X-ray source technology for a broad range of diagnostic imaging applications.

(Logo: )

X-ray radiation is widely used today for a broad range of applications, including medical imaging and therapy, homeland security, and industrial inspection. The basic design of the X-ray tubes, however, has not changed significantly since Roentgen's discovery over a hundred years ago. Siemens and Xintek have developed a nanotechnology-based field emission X-ray source technology that fundamentally changes how X-ray radiation is generated and utilized. This technology is expected to enable new diagnostic imaging systems with enhanced performance and new capabilities.

"Siemens has a long, proud history as a leader in the development of X-ray sources for various imaging applications," said Peter Schardt, Ph.D., department head, research and development, Siemens Medical Solutions. "Through our joint venture with Xintek we look forward to adding another chapter in our history of innovation by further advancing X-ray with the incorporation of breakthrough nanotechnologies."

"We are pleased to form this joint venture with Siemens and look forward to working together to realize the potential opportunities in bringing nanotechnology and X-ray technology together in the diagnostic X-ray imaging field," said Otto Zhou, Ph.D., chairman, Xintek.

The joint venture company combines the activities Siemens and Xintek have been undertaking jointly over the last two years under one roof in North Carolina and is staffed by a strong technical team transferred from Xintek and Siemens facilities in Germany and China.

About Xintek

Xintek Inc. is based in the Research Triangle Park of North Carolina. The company develops nanotechnology-based products for industries, including X-ray imaging and information display. Xintek is a spin-off from the University of North Carolina at Chapel Hill. Additional information regarding Xintek can be found at

About Siemens Medical Solutions

Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics -- such as Diagnostic Products Corporation and Bayer Diagnostics -- mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Siemens health services president calls IT benefits unassailable
2. Joint Finance blocks Doyle ethanol measure
3. StrandVision signs joint marketing agreement with Pacific Signage
4. Joint Venture Trains Minority Students for IT Careers
5. Venture Investors early-stage fund grows to $115 million
6. Investor warns of angel-venture funding gap
7. Visions: Broderick says Wisconsin should be in top third in venture capital
8. Wisconsin building toward the major leagues of venture capital
9. Biotech officials praise focus of new venture fund
10. Alzheimers drug developer lands $1.2M in venture funding
11. Capital-raising term sheets for angels and venture capitalists
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> Accutest Research Laboratories, ... Contract Research Organization (CRO), has formed ... Cancer Center - Temple Health for ... ,     (Photo: ) , ...
(Date:11/25/2015)... November 25, 2015 2 nouvelles études ... les différences entre les souches bactériennes retrouvées dans ... des êtres humains . Ces recherches  ouvrent une ... la prise en charge efficace de l,un des ... les chats .    --> 2 nouvelles ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... featured on AngelList early in their initial angel funding process. Now, they are ... individuals looking to make early stage investments in the microbiome space. In ...
Breaking Biology Technology:
(Date:11/16/2015)... SAN JOSE, Calif. , Nov 16, 2015 ... leading developer of human interface solutions, today announced ... new Synaptics TouchView ™ touch controller and ... the architectural revolution of smartphones. These new TDDI ... and include TD4100 (HD resolution), TD4302 (WQHD resolution), ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):